Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
X Financial A ADR | XYF | Apr 26, 2024 | 3.85 | +1.48 |
X3 Holdings | XTKG | Apr 26, 2024 | 0.64 | 0.00 |
X4 Pharmaceuticals | XFOR | Apr 26, 2024 | 1.17 | +3.10 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Apr 26, 2024 | 7.02 | +0.14 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Apr 26, 2024 | 24.60 | +0.61 |
XBiotech | XBIT | Apr 26, 2024 | 7.87 | -4.14 |
XBP Europe | XBP | Apr 26, 2024 | 1.50 | +19.05 |
Xcel Brands | XELB | Apr 26, 2024 | 0.69 | -3.41 |
Xcel Energy | XEL | Apr 26, 2024 | 53.96 | -1.91 |
Xencor | XNCR | Apr 26, 2024 | 19.98 | +3.90 |
Xenetic Biosciences | XBIO | Apr 26, 2024 | 4.09 | +8.32 |
Xenia Hotels & Resorts | XHR | Apr 26, 2024 | 14.13 | -0.07 |
Xenon Pharmaceuticals | XENE | Apr 26, 2024 | 40.50 | +1.00 |
Xeris Biopharma | XERS | Apr 26, 2024 | 1.75 | +2.94 |
Xerox | XRX | Apr 26, 2024 | 14.00 | -1.27 |
XIAO-I ADR | AIXI | Apr 26, 2024 | 1.28 | 0.00 |
Xilio Therapeutics | XLO | Apr 26, 2024 | 1.09 | +7.92 |
Xinyuan Real Estate ADR | XIN | Apr 26, 2024 | 2.72 | 0.00 |
XOMA | XOMA | Apr 26, 2024 | 25.41 | +0.20 |
XOMA A Pref | XOMAP | Apr 26, 2024 | 24.97 | -0.08 |
XOMA B Pref | XOMAO | Apr 26, 2024 | 24.97 | -0.12 |
Xometry A | XMTR | Apr 26, 2024 | 17.53 | +3.61 |
XORTX Therapeutics | XRTX | Apr 26, 2024 | 2.93 | +13.13 |
Xos | XOS | Apr 26, 2024 | 7.56 | -0.40 |
XP A | XP | Apr 26, 2024 | 21.06 | +2.48 |
XPEL | XPEL | Apr 26, 2024 | 54.74 | +1.80 |
XPeng A ADR | XPEV | Apr 26, 2024 | 7.84 | +10.73 |
Xperi | XPER | Apr 26, 2024 | 9.95 | +1.22 |
XPO Logistics | XPO | Apr 26, 2024 | 110.90 | -6.22 |
Xponential Fitness A | XPOF | Apr 26, 2024 | 12.81 | +2.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.